Collagenase Clostridium Histolyticum For The Investigational … – Markets Insider


GuruFocus.com

Collagenase Clostridium Histolyticum For The Investigational …
Markets Insider
DUBLIN, April 27, 2018 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) today announced the presentation of clinical data from a Phase 2b investigational study of collagenase clostridium histolyticum (CCH) for the treatment of cellulite. Dr
Collagenase Clostridium Histolyticum For The Investigational Treatment Of Cellulite To Be Featured During The Hot …PR Newswire (press release)

all 1 news articles »

Read more: markets.businessinsider.com

About the Author AdelinaDuh

Leave a Comment: